The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center
Abstract
PURPOSE: Less than 5% of patients with cancer enroll in clinical trials, and 1 in 5 trials are stopped for poor accrual. We evaluated an automated clinical trial matching system that uses natural language processing to extract patient and trial characteristics from unstructured sources and machine learning to match patients to clinical trials. PATIENTS AND METHODS: Medical records from 997 patients with breast cancer were assessed for trial eligibility at Highlands Oncology Group between May and August 2016. System and manual attribute extraction and eligibility determinations were compared using the percentage of agreement for 239 patients and 4 trials. Sensitivity and specificity of system-generated eligibility determinations were measured, and the time required for manual review and system-assisted eligibility determinations were compared. RESULTS: Agreement between system and manual attribute extraction ranged from 64.3% to 94.0%. Agreement between system and manual eligibility determinations was 81%-96%. System eligibility determinations demonstrated specificities between 76% and 99%, with sensitivities between 91% and 95% for 3 trials and 46.7% for the 4th. Manual eligibility screening of 90 patients for 3 trials took 110 minutes; system-assisted eligibility determinations of the same patients for the same trials required 24 minutes. CONCLUSION: In this study, the clinical trial matching system displayed a promising performance in screening patients with breast cancer for trial eligibility. System-assisted trial eligibility determinations were substantially faster than manual review, and the system reliably excluded ineligible patients for all trials and identified eligible patients for most trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bidirectional Encoder Representations from Transformers (BERT)-based tools have been used for subject matching across various diseases while struggling with generalizability [4–7].”
From Enhancing hepatopathy clinical trial efficiency: a secure, large language model-powered pre-screening pipeline (2025) · cites this paper as [5]
In the citing paper
“Systems parse biomarker requirements, prior therapies, and performance status from EHRs, identify potentially eligible patients, and flag candidates for screening [56,57,58,59,60,61,62].”
From Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery (2025) · cites this paper as [59]
Citations
Cites
Use of Ranks in One-Criterion Variance Analysis
Kruskal, W. H., & Wallis, W. A. (1952) · Journal of the American Statistical Association · doi:10.1080/01621459.1952.10483441 · Cited by 13,912
What can natural language processing do for clinical decision support?
Demner‐Fushman, D., Chapman, W. W., & McDonald, C. J. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2009.08.007 · Cited by 716
The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies
Unger, J. M., Cook, E., Tai, E., & Bleyer, A. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_156686 · Cited by 665
Carlisle, B., Kimmelman, J., Ramsay, T., & MacKinnon, N. (2015) · Clinical Trials · doi:10.1177/1740774514558307 · Cited by 367
Adult cancer clinical trials that fail to complete: an epidemic?
Stensland, K. D., McBride, R. B., Latif, A., Wisnivesky, J., Hendricks, R., Roper, N., Boffetta, P., Hall, S. J., Oh, W. K., & Galsky, M. D. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju229 · Cited by 161
Ni, Y., Wright, J., Perentesis, J., Lingren, T., Deleger, L., Kaiser, M., Kohane, I., & Solti, I. (2015) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-015-0149-3 · Cited by 142
A National Cancer Clinical Trials System for the 21st Century
Board on Health Care Services (2010) · National Academies Press eBooks · doi:10.17226/12879 · Cited by 135
Ni, Y., Kennebeck, S., Dexheimer, J. W., McAneney, C. M., Tang, H., Lingren, T., Li, Q., Zhai, H., & Solti, I. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002887 · Cited by 115
Artificial Intelligence, Big Data, and Cancer
Kantarjian, H. M., & Yu, P. P. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1203 · Cited by 105
Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing
Patel, N. M., Michelini, V. V., Snell, J. M., Balu, S., Hoyle, A. P., Parker, J. S., Hayward, M. C., Eberhard, D. A., Salazar, A. H., McNeillie, P., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0170 · Cited by 103
Research works printed but not linked: 1
- Shivade C, 2017, AMIA Annu Symp Proc, 2016, 1149
Cited by
Sorted by citations
Artificial Intelligence and Human Trust in Healthcare: Focus on Clinicians
Asan, O., Bayrak, A. E., & Choudhury, A. (2020) · Journal of Medical Internet Research · doi:10.2196/15154 · Cited by 825
The Role of Artificial Intelligence in Early Cancer Diagnosis
Hunter, B., Hindocha, S., & Lee, R. W. (2022) · Cancers · doi:10.3390/cancers14061524 · Cited by 384
Artificial intelligence applied to clinical trials: opportunities and challenges
Askin, S., Burkhalter, D., Calado, G., & El Dakrouni, S. (2023) · Health and Technology · doi:10.1007/s12553-023-00738-2 · Cited by 285
Current AI technologies in cancer diagnostics and treatment
Tiwari, A., Mishra, S. N., & Kuo, T. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02369-9 · Cited by 257
Benefits and Risks of AI in Health Care: Narrative Review
Chustecki, M. (2024) · Interactive Journal of Medical Research · doi:10.2196/53616 · Cited by 208
“AI-powered programs can simulate and evaluate numerous potential treatments to predict their effectiveness against various diseases, optimizing the drug development process in clinical trials [34].”
The Lancet Breast Cancer Commission
Coles, C. E., Earl, H. M., Anderson, B. O., Barrios, C. H., Bienz, M., Bliss, J. M., Cameron, D., Cardoso, F., Cui, W., Francis, P. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00747-5 · Cited by 209
The future of pharmaceuticals: Artificial intelligence in drug discovery and development
Fu, C., & Chen, Q. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101248 · Cited by 151
The emerging roles of artificial intelligence in cancer drug development and precision therapy
Liang, G., Fan, W., Luo, H., & Zhu, X. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110255 · Cited by 149
Artificial intelligence in cancer diagnosis and therapy: Current status and future perspective
Sufyan, M., Shokat, Z., & Ashfaq, U. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107356 · Cited by 170
An Overview of Artificial Intelligence in Oncology
Farina, E. M. J. D. M., Nabhen, J. J., Dacoregio, M. I., Batalini, F., & de Moraes, F. Y. (2022) · Future Science OA · doi:10.2144/fsoa-2021-0074 · Cited by 145
Haddad, T. C., Helgeson, J. M., Pomerleau, K., Preininger, A. M., Roebuck, M. C., Dankwa‐Mullan, I., Jackson, G. P., & Goetz, M. P. (2021) · JMIR Medical Informatics · doi:10.2196/27767 · Cited by 79
Harnessing artificial intelligence to improve clinical trial design
Zhang, B., Zhang, L., Chen, Q., Jin, Z., Liu, S., & Zhang, S. (2023) · Communications Medicine · doi:10.1038/s43856-023-00425-3 · Cited by 80
Lu, X., Yang, C., Liang, L., Hu, G., Zhong, Z., & Jiang, Z. (2024) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocae243 · Cited by 77
“The output produced from WCTM’s trial intake process details criteria for the trial and provides additional information related to clinical concepts and values with associated WCTM attributes 22 ; (3) Enhancing patient identification.”
BackgroundMethodHallmarks of artificial intelligence contributions to precision oncology
Chang, T., Park, S., Schäffer, A. A., Jiang, P., & Ruppin, E. (2025) · Nature Cancer · doi:10.1038/s43018-025-00917-2 · Cited by 83
Clinical Natural Language Processing for Radiation Oncology: A Review and Practical Primer
Bitterman, D. S., Miller, T. A., Mak, R. H., & Savova, G. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.01.044 · Cited by 68
Chow, R., Midroni, J., Kaur, J., Boldt, G., Liu, G., Eng, L., Liu, F.-F., Haibe-Kains, B., Lock, M., & Raman, S. (2023) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djad013 · Cited by 65
Open challenges and opportunities in federated foundation models towards biomedical healthcare
Li, X., Peng, L., Wang, Y., & Zhang, W. (2025) · BioData Mining · doi:10.1186/s13040-024-00414-9 · Cited by 84
Artificial intelligence-based biomarkers for treatment decisions in oncology
Ligero, M., Nahhas, O. S. M. E., Aldea, M. D., & Kather, J. N. (2025) · Trends in cancer · doi:10.1016/j.trecan.2024.12.001 · Cited by 74
Perceptions and detection of AI use in manuscript preparation for academic journals
Chemaya, N., & Martin, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304807 · Cited by 70
Idnay, B., Dreisbach, C., Weng, C., & Schnall, R. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocab228 · Cited by 58
Scoping review of the current landscape of AI-based applications in clinical trials
Cascini, F., Beccia, F., Causio, F. A., Melnyk, A., Zaino, A., & Ricciardi, W. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.949377 · Cited by 49
The role of artificial intelligence in hastening time to recruitment in clinical trials
Ismail, A., Al-Zoubi, T., Naqa, I. E., & Saeed, H. (2023) · BJR|Open · doi:10.1259/bjro.20220023 · Cited by 47
AI in Healthcare: medical and socio-economic benefits and challengesPreprint
Shaheen, M. Y. (2021) · doi:10.14293/s2199-1006.1.sor-.pprqni1.v1 · Cited by 43
Liu, T., Gao, Z., & Guan, H. (2021) · Complexity · doi:10.1155/2021/5588650 · Cited by 42
RetractedNext-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health
Banerjee, R. K., Shah, N. D., & Dicker, A. P. (2021) · JCO Clinical Cancer Informatics · doi:10.1200/cci.21.00023 · Cited by 38
Application of Information Technology to Clinical Trial Evaluation and Enrollment: A Review
von Itzstein, M. S., Hullings, M., Mayo, H., Beg, M. S., Williams, E. L., & Gerber, D. E. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1165 · Cited by 36
Artificial intelligence in oncology: From bench to clinic
Elkhader, J. A., & Elemento, O. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.013 · Cited by 39
Bueschbell, B., Caniceiro, A. B., Suzano, P. M. S., Machuqueiro, M., Rosário‐Ferreira, N., & Moreira, I. S. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100811 · Cited by 38
Accelerating drug discovery, development, and clinical trials by artificial intelligence
Zhang, Y., Mastouri, M., & Zhang, Y. (2024) · Med · doi:10.1016/j.medj.2024.07.026 · Cited by 32
Evolution of artificial intelligence as a modern technology in advanced cancer therapy
Khan, M. S., Alshahrani, M. Y., Wahab, S., Gupta, G., & Kesharwani, P. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105892 · Cited by 36
The biomedical applications of artificial intelligence: an overview of decades of research
Naskar, S., Sharma, S., Kuotsu, K., Halder, S., Pal, G., Saha, S., Mondal, S., Biswas, U. K., Jana, M., & Bhattacharjee, S. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2024.2448711 · Cited by 35
Meystre, S. M., Heider, P. M., Cates, A., Bastian, G., Pittman, T., Gentilin, S. M., & Kelechi, T. J. (2023) · BMC Medical Research Methodology · doi:10.1186/s12874-023-01916-6 · Cited by 30
Kirshner, J. J., Cohn, K., Dunder, S., Donahue, K., Richey, M., Larson, P., Sutton, L. H., Siu, E., Donegan, J., Chen, Z., et al. (2021) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00180 · Cited by 23
A comprehensive review of artificial intelligence for pharmacology research
Li, B., Tan, K., Lao, A. R., Wang, H., Zheng, H., & Zhang, L. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1450529 · Cited by 26
Artificial intelligence, medications, pharmacogenomics, and ethics
Haga, S. B. (2024) · Pharmacogenomics · doi:10.1080/14622416.2024.2428587 · Cited by 25
Applying advanced technologies to improve clinical trials: a systematic mapping study
Ngayua, E. N., He, J., & Agyei-Boahene, K. (2020) · Scientometrics · doi:10.1007/s11192-020-03774-1 · Cited by 19
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms
Saini, K. S., Heras, B. D. L., Plummer, R., Moreno, V., Romano, M., de Castro, J., Aftimos, P. G., Fredriksson, J., Bhattacharyya, G. S., Olivo, M. S., et al. (2020) · JCO Global Oncology · doi:10.1200/go.20.00346 · Cited by 19
Bikou, A., Deligianni, E., Dermiki‐Gkana, F., Liappas, N., Teriús-Padrón, J. G., Beltrán, M. E., Cabrera-Umpiérrez, M. F., & Kontogiorgis, C. A. (2024) · Journal of Medical Internet Research · doi:10.2196/60504 · Cited by 21
Challenges and applications in generative AI for clinical tabular data in physiology
Umesh, C., Mahendra, M., Bej, S., Wolkenhauer, O., & Wolfien, M. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03024-w · Cited by 20
Potential application of artificial intelligence in cancer therapy
Riaz, I. B., Khan, M. A., & Haddad, T. C. (2024) · Current Opinion in Oncology · doi:10.1097/cco.0000000000001068 · Cited by 19
Beyond boundaries: exploring the transformative power of AI in pharmaceuticals
Suri, G. S., Kaur, G., & Shinde, D. A. (2024) · Discover Artificial Intelligence · doi:10.1007/s44163-024-00192-7 · Cited by 21
Wang, K., Cui, H., Zhu, Y., Hu, X., Chang, H. H., Guo, Y., An, L., Zhang, Q., & Liu, L. (2024) · BMC Cancer · doi:10.1186/s12885-024-11959-7 · Cited by 17
Saady, M., Eissa, M., Yacoub, A. S., Hamed, A. B., & Azzazy, H. M. E.-S. (2025) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2025.103066 · Cited by 15
AI in Healthcare: medical and socio-economic benefits and challengesPreprint
Shaheen, M. Y. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3932277 · Cited by 15
Use of AI as a Research Recruitment Tool: Ethical Elements, Considerations, and Recommendations
Rentzepis, P. J., Snyder, D. L., Baker, T. J., & Bierer, B. E. (2026) · The American Journal of Bioethics · doi:10.1080/15265161.2026.2649234 · Cited by 14
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Karsten, H., Matrisch, L., Cichutek, S., Fiedler, W., Alsdorf, W. H., & Block, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285406 · Cited by 15
AI in Healthcare: medical and socio-economic benefits and challengesPreprint
Shaheen, M. Y. (2021) · doi:10.31219/osf.io/um38t · Cited by 14
Alqahtani, A. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6201067 · Cited by 13
RetractedGhosh, S., Abushukair, H. M., Ganesan, A., Pan, C., Naqash, A. R., & Lü, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311510 · Cited by 17
Wu, J., Yakubov, A., Abdul‐Hay, M., Love, E., Kroening, G., Cohen, D., Spalink, C., Joshi, A., Balar, A. V., Joseph, K.-A., et al. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00629 · Cited by 10
Molecular-based precision oncology clinical decision making augmented by artificial intelligence
Zeng, J., & Shufean, M. A. (2021) · Emerging Topics in Life Sciences · doi:10.1042/etls20210220 · Cited by 11
Casolino, R., Mateo, J., de Vries, E. G. E., Johns, A. J., Courtot, M., Lawlor, R. T., Perdomo, S., Gray, S. W., Pérez-López, R., Turnbull, C., et al. (2026) · The Lancet Oncology · doi:10.1016/s1470-2045(26)00302-5 · Cited by 11
Is There a Role of Artificial Intelligence in Preclinical Imaging?
Küper, A. T., Blanc‐Durand, P., Gafita, A., Kersting, D., Fendler, W. P., Seibold, C., Moraitis, A., Lückerath, K., James, M. L., & Seifert, R. (2023) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2023.03.003 · Cited by 10
Clinical Informatics Approaches to Understand and Address Cancer Disparities
Chaunzwa, T. L., del Rey, M. Q., & Bitterman, D. S. (2022) · Yearbook of Medical Informatics · doi:10.1055/s-0042-1742511 · Cited by 10
Rani, S., & Jain, A. (2023) · Multimedia Tools and Applications · doi:10.1007/s11042-023-15539-y · Cited by 10
Hurd, T. C., Payton, F. C., & Hood, D. B. (2024) · Milbank Quarterly · doi:10.1111/1468-0009.12712 · Cited by 9
Lee, K., Mai, Y., Liu, Z., Raja, K., Higashi, M. K., Jun, T., Ma, M., Wang, T., Ai, L., Calay, E., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-77447-x · Cited by 14
Fernández, M. A., Astobiza, A. M., & Lozano, R. O. (2025) · Artificial Intelligence Review · doi:10.1007/s10462-025-11306-7 · Cited by 10
Review of the Performance Metrics for Natural Language Systems for Clinical Trials Matching
Kim, J., & Quintana, Y. (2022) · Studies in health technology and informatics · doi:10.3233/shti220156 · Cited by 8
Gui, X., Lv, H., Wang, X., Lv, L., Xiao, Y., & Wang, L. (2025) · BioData Mining · doi:10.1186/s13040-025-00458-5 · Cited by 10
Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery
Kuno, M., Osumi, H., Udagawa, S., Yoshikawa, K., Ooki, A., Shinozaki, E., Ishikawa, T., Oba, J., Yamaguchi, K., & Sakurada, K. (2025) · Current Oncology · doi:10.3390/curroncol32110588 · Cited by 7
Mallahan, S., Gajra, A., Blau, S. H., Peguero, J. A., Shoukier, M., Kanaan, M. N., Huynh, C. T., Efiom-Ekaha, D. N., Vankayala, H. M., Kitchen, K., et al. (2024) · AI in Precision Oncology · doi:10.1089/aipo.2024.0030 · Cited by 5
Vaterkowski, M., Daniel, C., Rosa, A. L., Kalra, D., Jaulent, M., Lamé, G., & Kempf, E. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.105900 · Cited by 8
Rosa, A. L., Vaterkowski, M., Marc Cuggia, A., Campillo‐Gimenez, B., Tournigand, C., BAUJAT, B., Daniel, C., Kempf, E., & Lamé, G. (2024) · Cancer Medicine · doi:10.1002/cam4.70466 · Cited by 4
A unified framework for pre-screening and screening tools in oncology clinical trials
Horgan, D., Paulson, J., Loaiza‐Bonilla, A., Svedman, C., Malapelle, U., Penault-Llorca, F. M., Rasheed, H. M. A., Hofman, P. M., Kachnowski, S., Schneider, D. J., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01306-3 · Cited by 6
AI-enhanced patient-centric clinical trial design
Gupta, Y., Srivastava, V. P., & Singh, R. K. (2025) · AIP conference proceedings · doi:10.1063/5.0247858 · Cited by 5
Revolutionizing Health Records: The AI Way
Saranya, S. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24417190214 · Cited by 5
Artificial Intelligence in Cancer Diagnosis: A Game-changer in Healthcare
Sahoo, P., Kundu, M., & Begum, J. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010298852240528123911 · Cited by 8
The Role of Artificial Intelligence in Urogynecology: Current Applications and Future Prospects
de Oliveira, M. B. M., Mendes, F., Martins, M., Cardoso, P., Fonseca, J., Mascarenhas, T., & Mascarenhas, M. (2025) · Diagnostics · doi:10.3390/diagnostics15030274 · Cited by 8
Versteijne, E., Suker, M., Groen, J. V., Besselink, M. G., Bonsing, B. A., Bosscha, K. P., Busch, O. R., de Hingh, I. H. J. T., de Jong, K. P., Molenaar, I. Q., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004364 · Cited by 5
RE: Use of artificial intelligence for cancer clinical trial enrollment
Deng, J., & Heybati, K. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad228 · Cited by 5
Artificial intelligence for clinical trial design, conduct, and analysis: a narrative review
Knapen, D. G., van Kruchten, M., de Groot, D. J. A., Broekman, K. E., & Fehrmann, R. S. N. (2026) · ESMO Real World Data and Digital Oncology · doi:10.1016/j.esmorw.2026.100682 · Cited by 6
Dafni, M. F., Shih, M., Manoel, A. Z., Yousif, M., Spathi, S., Harshal, C., Bhatt, G., Chodnekar, S. Y., Stam, N., Rasool, W., et al. (2024) · Cancer Causes & Control · doi:10.1007/s10552-024-01942-9 · Cited by 4
Artificial Intelligence in Oncology
Jeziorski, K., & Olszewski, R. (2024) · Applied Sciences · doi:10.3390/app15010269 · Cited by 4
Mehari, M., Warrier, G., Dada, A., Kabir, A., Haskell-Mendoza, A. P., Tripathy, A., Jha, R., Nieblas‐Bedolla, E., Jackson, J. D., Gonzalez, A. T., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt5708 · Cited by 5
Mbatha, S. Z., Mulaudzi, T. V., Mbita, Z., Adeola, H. A., Batra, J., Blenman, K., & Dlamini, Z. (2023) · Springer eBooks · doi:10.1007/978-3-031-36461-7_7 · Cited by 5
Guillotel, L.-A., Lesimple, T., Zékri, O., Marc Cuggia, A., & Campillo‐Gimenez, B. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106301 · Cited by 3
Research and application of omics and artificial intelligence in cancer
Zhang, Y., Ma, W., Huang, Z., Liu, K., Feng, Z., Zhang, L., Li, D., Mo, T., & Liu, Q. (2024) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ad6951 · Cited by 3
Chadha, S., Mukherjee, S., & Sanyal, S. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152349 · Cited by 6
Molefi, T., Marima, R. M., Demetriou, D., Basera, A., & Dlamini, Z. (2023) · Springer eBooks · doi:10.1007/978-3-031-21506-3_13 · Cited by 4
Challenges, Limitations, and Ethical Considerations of AI in Immunology and Healthcare
Rajchenberg, D., Hess, R., Lins, M. P., Manor, A., Degany, O., & Shoenfeld, Y. (2025) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3693-9725-1.ch014 · Cited by 3
Ronquillo, J. G., & Lester, W. T. (2021) · JCO Clinical Cancer Informatics · doi:10.1200/cci.21.00018 · Cited by 3
Goodwin, A. J., Armstrong, S. A., Ptak, D., Catchpole, K. C., Obeid, J. S., & Heider, P. M. (2025) · JMIR Formative Research · doi:10.2196/71831 · Cited by 2
Multi-objective optimization formulation for Alzheimer’s disease trial patient selection
Moayedikia, A., Fin, S., & Wiil, U. K. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2025.104955 · Cited by 2
Gedor, M., Désandes, E., Chesnel, M., Merlin, J., Marchal, F., Lambert, A., & Baudin, A. (2024) · Bulletin du Cancer · doi:10.1016/j.bulcan.2024.01.010 · Cited by 2
Mkhize‐Kwitshana, Z. L., Naidoo, P., Duma, Z., Saini, K. S., & Dlamini, Z. (2024) · Springer eBooks · doi:10.1007/978-3-031-52860-6_10 · Cited by 3
Clinical Data Abstraction: A Research Study.
Watzlaf, V. J. M., Sheridan, P. T., Alzu'bi, A. A., & Chau, L. (2021) · PubMed Central · Cited by 2
Artificial intelligence in the treatment of cancer: Changing patterns, constraints, and prospects
Ali, M., Wani, S. U. D., Dey, T., & Mehdi, S. (2024) · Health and Technology · doi:10.1007/s12553-024-00825-y · Cited by 2
Benbow, J. H., & Kim, E. S. (2025) · The Cancer Journal · doi:10.1097/ppo.0000000000000796 · Cited by 1
Pollák, P., Barótfi, S., Csóka, I., & Budai-Szűcs, M. (2025) · Orvosi Hetilap · doi:10.1556/650.2025.33420 · Cited by 1
Claessens, A., Simon, A., Manchart, A., Desmonts, L., Leguay, C., Faivre, J.-C., Cambier, S., Salleron, J., & Lambert, A. (2026) · JMIR Cancer · doi:10.2196/80268 · Cited by 2
Korsah, M. A., Sewu, D. D., Patel, P., Jeevanandam, J., Ponnuchamy, K., & Danquah, M. K. (2026) · Next research. · doi:10.1016/j.nexres.2026.101735 · Cited by 1
A review on artificial intelligence in pharmaceutical sciences: opportunities and challenges
Kumar, V., Kumar, U., Kumar, R., Tiwari, N., & Gupta, J. K. (2026) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2026.2670435 · Cited by 2
Kayira, A. B., Elyazori, H. R. A., Lybarger, K., Walter, F. M., Chelala, C., & Funston, G. (2026) · JMIR AI · doi:10.2196/73481 · Cited by 2
Das, S. K., Talukdar, A. D., Nath, D., & Choudhury, M. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15280-1.00007-8 · Cited by 1
Lutz, J., Pratap, A., Lenze, E. J., Bestha, D. P., Lipschitz, J. M., Karantzoulis, S., Vaidyanathan, U., Robin, J., Horan, W. P., Brannan, S. K., et al. (2023) · PubMed Central · Cited by 1
HARNESSING ARTIFICIAL INTELLIGENCE FOR REAL-TIME QUALITY ASSURANCE IN MEDICAL DEVICE MANUFACTURING
Barla, P. C., & Karthikeyan, L. (2024) · The American Journal of Engineering And Technology · doi:10.37547/tajet/volume06issue06-04 · Cited by 2
Naidu, G., & Krishnan, V. (2025) · International Journal of Intelligence Science · doi:10.4236/ijis.2025.151002 · Cited by 3
Lee, K., Mai, Y., Liu, Z., Raja, K., Jun, T. W., Ma, M., Wang, T., Ai, L., Calay, E. S., Oh, W. K., et al. (2024) · medRxiv · doi:10.1101/2024.02.28.24303396 · Cited by 1
ACCC Can Close the Gap in Cancer Research: The Research Program at Highlands Oncology Group
Patton, A. (2021) · Oncology Issues · doi:10.1080/10463356.2020.1849905
Metadata
- Authors
- Beck, J. T., Rammage, M., Jackson, G. P., Preininger, A. M., Dankwa-Mullan, I., Roebuck, M. C., Torres, A., Holtzen, H., Coverdill, S. E., Williamson, M. P., Chau, Q., Rhee, K., & Vinegra, M.
- Affiliations
- Highlands Oncology Group (US)
- IBM (United States) (US)
- IBM Watson Health, IBM Corporation, Cambridge, MA
- RxEconomics, Hunt Valley, MD
- Novartis (United States) (US)
- ORCID
- Venue
- JCO Clinical Cancer Informatics
- Published
- 2020-11
- Volume
- 4
- Issue
- 4
- Pages
- 50-59
- ISSN
- 2473-4276 (ISSN-L)
- OpenAlex
- W3001688612
- Cited by
- 127
- References
- 19
- Citations by year
- 2026: 17 · 2025: 28 · 2024: 33 · 2023: 20 · 2022: 7 · 2021: 16 · 2020: 5
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JCO Clinical Cancer Informatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
- Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
- Keywords
- clinical trial eligibility screening, natural language processing, machine learning, breast cancer, cancer clinical trials, trial accrual, attribute extraction
- MeSH terms
- Machine Learning, Adult, Aged, Aged, 80 and over, Artificial Intelligence, Breast Neoplasms, Clinical Trials as Topic, Eligibility Determination, Female, Humans, Middle Aged, Natural Language Processing, Patient Selection, Community Networks, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review